Levosimendan protects against ischemia – reperfusion injury in the human heart muscle. A pilot study

Levosimendan protects against ischemia – reperfusion injury in the human heart muscle. A pilot study

The consequences of myocardial infarction (MI) are an increasing problem worldwide. Despite spectacular progress in the invasive treatment of ischemic heart disease, the ability to limit the ischemia-reperfusion (I/R) injury remains largely unrealized. Recent studies have shown that stimulation of o...

Full description

Bibliographic Details
Main Authors: Kunecki Marcin, Oleksy Tomasz, Nozynski Jerzy, Podolec Piotr, Biernat Jolanta, Deja Marek Andrzej, Golba Krzysztof Stanislaw, Plazak Wojciech
Format: Article
Language:English
Published: Sciendo 2022-12-01
Series:Current Issues in Pharmacy and Medical Sciences
Subjects:
ischemia
reperfusion
levosimendan
morphology of mi
cardioprotection
Online Access:https://doi.org/10.2478/cipms-2022-0038

Internet

https://doi.org/10.2478/cipms-2022-0038

Similar Items